The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
Volume 357:1069-1071 September 13, 2007 Number 11
NextNext

Putting Typhoid Vaccination on the Global Health Agenda
Denise DeRoeck, M.P.H., Luis Jodar, Ph.D., and John Clemens, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Although typhoid fever, caused by infection with Salmonella enterica serovar Typhi (often called S. typhi), long ago ceased to be a public health problem in industrialized countries, it is still a substantial cause of illness and death in many developing countries. According to the World Health Organization (WHO), there are 16 million to 33 million cases and 500,000 to 600,000 deaths from typhoid fever annually,1 though one study conservatively estimated that 22 million cases and 216,000 related deaths occurred in 2000.2 This death rate is not much lower than the estimated 270,000 annual deaths from cervical cancer, caused largely . . . [Full Text of this Article]


Source Information

Ms. DeRoeck is the coordinator of social-science research and institutional development, Dr. Jodar the deputy director-general, and Dr. Clemens the director-general of the International Vaccine Institute, based in Seoul, Korea.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.